Thyroid Hormone Receptor Interactor 4 (TRIP4) (Middle Region) Peptid
TRIP4
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle TRIP4 Produkte
- TRIP4 (Thyroid Hormone Receptor Interactor 4 (TRIP4))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- FKKDEILDGQ KSGDHLKRGR KKGRNRQEVP AFTEPDTTAE VKTPFDLAKA
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- TRIP4 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TRIP4 (Thyroid Hormone Receptor Interactor 4 (TRIP4))
- Hintergrund
-
This gene encodes a subunit of the tetrameric nuclear activating signal cointegrator 1 (ASC-1) complex, which associates with transcriptional coactivators, nuclear receptors and basal transcription factors to facilitate nuclear receptors-mediated transcription. This protein is localized in the nucleus and contains an E1A-type zinc finger domain, which mediates interaction with transcriptional coactivators and ligand-bound nuclear receptors, such as thyroid hormone receptor and retinoid X receptor alpha, but not glucocorticoid receptor. Mutations in this gene are associated with spinal muscular atrophy with congenital bone fractures-1 (SMABF1).
Alias Symbols: ASC1, ASC-1, ZC2HC5, HsT17391
Protein Size: 581 - Gen-ID
- 9325
- NCBI Accession
- NM_016213, NP_057297
- UniProt
- Q15650
-
Sie sind hier:
